Recent News for LLY - Eli Lilly and Company

Date Title
Aug 20 UPDATE 2-Elanco to become No.2 in animal health with $7.6 bln Bayer deal
Aug 19 Longtime Genentech exec retiring as new CEO settles in
Aug 19 Lilly Announces Webcast to Discuss World Conference on Lung Cancer Presentation
Aug 19 Eli Lilly Taltz Data Points To A Solid Push Into The Psoriasis Space
Aug 19 UPDATE 1-Roche taps Lilly executive Garraway as chief medical officer
Aug 19 Roche taps Eli Lilly executive as chief medical officer
Aug 19 Roche prices Rozlytrek below Bayer & Lilly's Vitrakvi
Aug 16 How AbbVie Plans To Take On Pfizer, Lilly — And Kick Its Humira Habit
Aug 16 FDA OKs AbbVie's Rinvoq rheumatoid arthritis; shares up 2%
Aug 16 Pharma Stock Roundup: Pipeline/Regulatory Updates From JNJ, LLY, AZN, RHHBY
Aug 16 Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe
Aug 15 Agios Rides High on Tibsovo Sales Amid Acute Competition
Aug 14 Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
Aug 14 Lilly's Taltz Outshines J&J's Tremfya in Psoriasis Study
Aug 14 Lilly Launches Open Innovation Challenge to Help Transform Inflammatory Bowel Disease (IBD) Care through Digital Health
Aug 13 Lilly's Psoriasis Drug Found Superior To J&J's Tremfya In Phase 4 Study
Aug 13 Lilly's Taltz beats J&J's Tremfya in post-market psoriasis study
Aug 13 Lilly Announces Superiority of Taltz® (ixekizumab) versus TREMFYA® (guselkumab) in Delivering Total Skin Clearance at Week 12 in Topline Results from Head-to-Head (IXORA-R) Trial in People Living with Moderate to Severe Plaque Psoriasis
Aug 13 8 Stocks That Have Paid a Dividend for 125 (or More) Consecutive Years
Aug 13 How one Boston startup rode the diabetes investment wave to raise $126M
Aug 13 Eli Lilly Looks To Positive Data To Expand Its Market Opportunity For Emgality
Aug 11 Pharmaceutical groups should invest in public health systems
Aug 11 US patients struggle to obtain Eli Lilly’s half-price insulin
Aug 10 Dividend Investors: Don't Be Too Quick To Buy Eli Lilly and Company (NYSE:LLY) For Its Upcoming Dividend
Aug 10 Dicerna Pharmaceuticals Inc (DRNA) Q2 2019 Earnings Call Transcript
Back to the Main LLY Page...